Home » Topics » Regulatory » Patents

Patents
RSS

Grey Wolf Therapeutics synthesizes ERAP1 inhibitors

June 10, 2020

Taisho Pharmaceutical discloses new antibacterials

June 10, 2020

Black Belt TX patents arginase inhibitors

June 10, 2020

Beijing Scitech-Mq Pharmaceuticals patents new compounds for cancer

June 9, 2020

Shanghai De Novo Pharmatech identifies ATR kinase inhibitors

June 9, 2020

Nanjing Sanhome Pharmaceutical synthesizes new TGFR-1 inhibitors

June 9, 2020

Inflazome patents NLRP3 inhibitors

June 9, 2020

Jiangsu Chia Tai Tianqing Pharmaceutical divulges HBV antivirals

June 9, 2020

New arginase inhibitors presented by Arcus Biosciences

June 8, 2020

Inception IBD discloses new VNN1 inhibitors

June 8, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...